Mar 31st 2022 - JCVI Update for children and COVID-19 vaccines
As the national booking service for COVID-19 vaccines opens for Spring booster appointments, the NHS has made it easier for people with a weakened immune system to get the vaccinations they need. Children aged 5 to 11 at high risk The Joint Committee on Vaccination and Immunisation (JCVI) advises recommends that 5 to 11-year-olds who […]
Feb 21st 2022 - Coffee & Questions – Medicines for heart children
Our next Coffee & Questions will take place on Wednesday 2nd March 2022. Dr Abbas Khushnood, consultant in paediatric & congenital cardiology, will be answering your questions about medicines for children with heart conditions. Dr Abbas Khushnood was appointed as Consultant Paediatric Cardiologist at the Freeman Hospital, Newcastle in 2018. He has been the Network […]
Jan 19th 2022 - CHF Research Projects – tell us what you think about long term medicines for children
Through our work we have learned that there can be practical and emotional issues, as well as some positive experiences, that parents/carers encounter when giving long term medicines to children. We have therefore decided to support the running of a survey aimed at parents/carers of children on long term medicines designed to help us understand your […]
Dec 15th 2021 - BCCA News Update 14th December 2021 – Covid–19 Vaccination for children and young people
Covid–19 Vaccination for children and young people On 26 November 2021 WHO designated the COVID variant B.1.1.529 a “variant of concern”, named Omicron (WHO update on omicron 28 Nov 2021). In response to the emergence of this variant the JCVI has expedited and reviewed its advice for the UK vaccine response (JCVI advice for omicron 29 […]
Oct 27th 2021 - Updated BCCA Statement on COVID Vaccinations for Children and Young People
COVID19 Vaccination for children and young people The Pfizer/BioNTech vaccine was approved for use in children aged 12-15 years by the Medicines and Healthcare products Regulatory Agency (MHRA) on June 4th 2021. The Joint Committee for Vaccination and Immunisation (JCVI) recommended two doses of COVID-19 vaccine (Pfizer/BioNTech) for children between 12 and 18 years and either […]
